First CRISPR drug could be approved soon – DW – 11/02/2023
A CRISPR drug to treat sickle cell disease may be approved by the US drug regulator next month.
Source: dw.com
📰 Gil Wolfe News
Gil Wolfe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gil Wolfe. Real-time updates on events, politics, business and more.
Potential cure for sickle cell disease raises few concerns for FDA panel
Vertex Pharmaceuticals has hailed its treatment as "transformative" for patients with sickle cell disease. The FDA will decide on approval soon.
Source: cbsnews.com
FDA considers first CRISPR gene editing treatment that may cure sickle cell - Boston News, Weather, Sports
(CNN) — At age 45, Dr. Lakiea Bailey said, for the longest time, that she was the oldest person with sickle cell anemia that she knew. The executive<a class="excerpt-read-more" href="https://whdh.com/news/fda-considers-first-crispr-gene-editing-treatment-that-may-cure-sickle-cell/">Read More</a>
Source: whdh.com
Argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression in generalized myasthenia...
Source: marketscreener.com
argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including mini...
Source: businessinsider.com
FDA considers first CRISPR gene editing treatment that may cure sickle cell
(CNN) — At age 45, Dr. Lakiea Bailey said, she was the oldest person with sickle cell anemia that she knew.
Source: wthitv.com
FDA considers first CRISPR gene editing treatment that may cure sickle cell
(CNN) — At age 45, Dr. Lakiea Bailey said, she was the oldest person with sickle cell anemia that she knew.
Source: kdrv.com
Immunoglobulin Therapies in the US: How they are used, a Roundtable Report
On September 9, 2021, a panel of experts convened To discuss the use of immunoglobulin (Ig) therapies, Detail the therapeutic benefits of Ig therapies…
Source: lexology.com
argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings
Argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace
United States Chafic Karam Michelle Greenblatt Gregoryw Fulton Demyelinating Polyneuropathy Jeffrey Guptill
Source: biospace.com